Patents by Inventor Michael NIESMAN

Michael NIESMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230099852
    Abstract: Provided herein are compositions and methods for the treatment of autoimmune and alloimmune diseases and conditions, including rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease (IBD) (e.g., Crohn's disease, ulcerative colitis), optic neuritis, Neuromyelitis Optica, Sjögren's syndrome, psoriasis, systemic scleroderma, Ankylosing Spondylitis, autoimmune hepatitis, Graft vs host disease (GvHD), and organ transplant rejection. Said compositions useful for treating autoimmune diseases comprise pyrrolo-pyrazole PKC inhibitors.
    Type: Application
    Filed: October 28, 2022
    Publication date: March 30, 2023
    Inventors: Michael NIESMAN, Kai ZHANG
  • Publication number: 20230028918
    Abstract: The present invention relates, in some respects, to methods of using, and compositions comprising, a protein kinase inhibitor and pharmaceutically acceptable salts, solvates, and hydrates thereof. In some embodiments, the present invention relates to modified or extended release pharmaceutical formulations in the form of particles which, in some embodiments, are used in a tablet, capsule, or particulate form, for slowly releasing the protein kinase inhibitor, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, over periods of time from at least 8 to 12 hours. The compositions of the present invention are useful in the treatment of PKC? related disorders.
    Type: Application
    Filed: December 4, 2020
    Publication date: January 26, 2023
    Inventors: Michael NIESMAN, Kai ZHANG, Kay OLMSTEAD
  • Publication number: 20220202815
    Abstract: Provided herein are compositions and methods for the treatment of a hematological malignancy. Also disclosed herein are compositions and methods for the treatment of Ewing's Sarcoma. Said compositions comprise isoform selective pyrrolo-pyrazole PKC inhibitors.
    Type: Application
    Filed: September 10, 2021
    Publication date: June 30, 2022
    Inventors: Michael NIESMAN, Kai ZHANG
  • Publication number: 20220202814
    Abstract: Provided herein are compositions and methods for the treatment of a hematological malignancy. Also disclosed herein are compositions and methods for the treatment of Ewing's Sarcoma. Said compositions comprise isoform selective pyrrolo-pyrazole PKC inhibitors.
    Type: Application
    Filed: September 10, 2021
    Publication date: June 30, 2022
    Inventors: Michael NIESMAN, Kai ZHANG
  • Publication number: 20220000870
    Abstract: Provided herein are compositions and methods for the treatment of a hematological malignancy. Also disclosed herein are compositions and methods for the treatment of Ewing's Sarcoma. Said compositions comprise isoform selective pyrrolo-pyrazole PKC inhibitors.
    Type: Application
    Filed: September 8, 2021
    Publication date: January 6, 2022
    Inventors: Michael NIESMAN, Kai ZHANG
  • Publication number: 20210401837
    Abstract: Provided herein are compositions and methods for the treatment of a hematological malignancy. Also disclosed herein are compositions and methods for the treatment of Ewing's Sarcoma. Said compositions comprise isoform selective pyrrolo-pyrazole PKC inhibitors.
    Type: Application
    Filed: September 8, 2021
    Publication date: December 30, 2021
    Inventors: Michael NIESMAN, Kai ZHANG
  • Patent number: 11154555
    Abstract: Provided herein are compositions and methods for the treatment of a hematological malignancy. Also disclosed herein are compositions and methods for the treatment of Ewings Sarcoma. Said compositions comprise isoform selective pyrrolo-pyrazole PKC inhibitors.
    Type: Grant
    Filed: July 13, 2017
    Date of Patent: October 26, 2021
    Assignee: MINGSIGHT PHARMACEUTICALS, INC.
    Inventors: Michael Niesman, Kai Zhang
  • Publication number: 20210069194
    Abstract: Provided herein are compositions and methods for the treatment of a hematological malignancy. Also disclosed herein are compositions and methods for the treatment of Ewing's sarcoma. Said methods comprise the administration of isoform selective pyrrolo-pyrazole PKC inhibitors and CAR-T therapy.
    Type: Application
    Filed: January 17, 2019
    Publication date: March 11, 2021
    Inventors: Michael NIESMAN, Kai ZHANG
  • Publication number: 20190216809
    Abstract: Provided herein are compositions and methods for the treatment of a hematological malignancy. Also disclosed herein are compositions and methods for the treatment of Ewings Sarcoma. Said compositions comprise isoform selective pyrrolo-pyrazole PKC inhibitors.
    Type: Application
    Filed: July 13, 2017
    Publication date: July 18, 2019
    Applicant: MingSight Pharmaceuticals, Inc.
    Inventors: Michael NIESMAN, Kai ZHANG
  • Publication number: 20180318300
    Abstract: Provided herein are compositions and methods for the treatment of autoimmune and alloimmune diseases and conditions, including rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease (IBD) (e.g., Crohn's disease, ulcerative colitis), optic neuritis, Neuromyelitis Optica, Sjögren's syndrome, psoriasis, systemic scleroderma, Ankylosing Spondylitis, autoimmune hepatitis, Graft vs host disease (GvHD), and organ transplant rejection. Said compositions useful for treating autoimmune diseases comprise pyrrolo-pyrazole PKC inhibitors.
    Type: Application
    Filed: November 14, 2016
    Publication date: November 8, 2018
    Inventors: Michael NIESMAN, Kai ZHANG
  • Patent number: 9980965
    Abstract: Provided herein are compositions and methods for the treatment of autoimmune diseases, including lupus, uveitis and encephalitis. Said compositions useful for treating autoimmune diseases comprise pyrrolo-pyrazole PKC inhibitors.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: May 29, 2018
    Assignee: MINGSIGHT PHARMACEUTICALS, INC.
    Inventors: Michael Niesman, Kai Zhang
  • Publication number: 20180098988
    Abstract: Provided herein are compositions and methods for the treatment of autoimmune diseases, including lupus, uveitis and encephalitis. Said compositions useful for treating autoimmune diseases comprise pyrrolo-pyrazole PKC inhibitors.
    Type: Application
    Filed: October 19, 2017
    Publication date: April 12, 2018
    Inventors: Michael NIESMAN, Kai ZHANG
  • Patent number: 9814716
    Abstract: Provided herein are compositions and methods for the treatment of autoimmune diseases, including lupus, uveitis and encephalitis. Said compositions useful for treating autoimmune diseases comprise pyrrolo-pyrazole PKC inhibitors.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: November 14, 2017
    Assignee: MINGSIGHT PHARMACEUTICALS, INC.
    Inventors: Michael Niesman, Kai Zhang
  • Publication number: 20170196865
    Abstract: Provided herein are compositions and methods for the treatment of autoimmune diseases, including lupus, uveitis and encephalitis. Said compositions useful for treating autoimmune diseases comprise pyrrolo-pyrazole PKC inhibitors.
    Type: Application
    Filed: May 22, 2015
    Publication date: July 13, 2017
    Inventors: Michael NIESMAN, Kai ZHANG